相似文献
1
The molecular basis of IL-10 function: from receptor structure to the onset of signaling.
Curr Top Microbiol Immunol. 2014;380:191-212. doi: 10.1007/978-3-662-43492-5_9.
2
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
J Biol Chem. 2006 Nov 17;281(46):35088-96. doi: 10.1074/jbc.M606791200. Epub 2006 Sep 18.
3
Structural analysis of cytokines comprising the IL-10 family.
Cytokine Growth Factor Rev. 2010 Oct;21(5):325-30. doi: 10.1016/j.cytogfr.2010.08.003. Epub 2010 Sep 16.
4
Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions.
Eur Cytokine Netw. 2002 Jan-Mar;13(1):5-15.
5
Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
FEBS Lett. 2008 Sep 3;582(20):2985-92. doi: 10.1016/j.febslet.2008.07.046. Epub 2008 Aug 7.
6
Interleukin-10 (IL-10).
Cancer Treat Res. 1995;80:305-19. doi: 10.1007/978-1-4613-1241-3_12.
7
Structural analysis of IL-10 and Type I interferon family members and their complexes with receptor.
Adv Protein Chem. 2004;68:171-223. doi: 10.1016/S0065-3233(04)68006-5.
8
Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.
Immunity. 2001 Jul;15(1):35-46. doi: 10.1016/s1074-7613(01)00169-8.
9
Interleukin-10 and related cytokines and receptors.
Annu Rev Immunol. 2004;22:929-79. doi: 10.1146/annurev.immunol.22.012703.104622.
10
Structural features of the interleukin-10 family of cytokines.
Curr Pharm Des. 2004;10(31):3873-84. doi: 10.2174/1381612043382602.
引用本文的文献
1
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches.
Signal Transduct Target Ther. 2025 Jul 31;10(1):227. doi: 10.1038/s41392-025-02280-1.
2
Atheroprotective Immunity and Interleukin-10 Linked to Reduced Characteristics of Plaque Stability.
JACC Basic Transl Sci. 2025 Jul 16;10(8):101322. doi: 10.1016/j.jacbts.2025.101322.
3
Interleukins as a potential link between obstructive sleep apnea and renal cell carcinoma.
Contemp Oncol (Pozn). 2025;29(2):131-149. doi: 10.5114/wo.2025.151584. Epub 2025 May 28.
4
CD206IL-4Rα Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
Circulation. 2025 Jul 29;152(4):257-273. doi: 10.1161/CIRCULATIONAHA.124.072411. Epub 2025 May 1.
5
IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives.
Cancers (Basel). 2025 Mar 17;17(6):1012. doi: 10.3390/cancers17061012.
6
Decreased IL-10R-expressing B Cells in breast cancer patients: a potential biomarker for early cancer detection.
Am J Clin Exp Immunol. 2025 Feb 25;14(1):34-42. doi: 10.62347/VYQY9361. eCollection 2025.
7
Regulatory role of microRNAs in virus-mediated inflammation.
J Inflamm (Lond). 2024 Nov 4;21(1):43. doi: 10.1186/s12950-024-00417-7.
8
Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication.
Rev Neurosci. 2024 Sep 3;36(1):91-117. doi: 10.1515/revneuro-2024-0081. Print 2025 Jan 29.
9
Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241240705. doi: 10.1177/03946320241240705.
10
Antibiotics against on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies.
Pharmaceutics. 2024 Jan 17;16(1):117. doi: 10.3390/pharmaceutics16010117.
本文引用的文献
1
Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.
J Allergy Clin Immunol. 2013 Mar;131(3):825-30. doi: 10.1016/j.jaci.2012.09.025. Epub 2012 Nov 14.
2
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F.
Nat Struct Mol Biol. 2012 Aug;19(8):754-9. doi: 10.1038/nsmb.2348. Epub 2012 Jul 22.
3
Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines.
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12704-9. doi: 10.1073/pnas.1117551109. Epub 2012 Jul 16.
4
Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties.
J Biol Chem. 2012 Aug 3;287(32):26586-95. doi: 10.1074/jbc.M112.376707. Epub 2012 Jun 12.
5
Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
PLoS One. 2012;7(5):e37931. doi: 10.1371/journal.pone.0037931. Epub 2012 May 24.
6
Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis.
FEMS Immunol Med Microbiol. 2012 Apr;64(3):295-313. doi: 10.1111/j.1574-695X.2012.00931.x. Epub 2012 Feb 14.
7
IL-10 elicits IFNγ-dependent tumor immune surveillance.
Cancer Cell. 2011 Dec 13;20(6):781-96. doi: 10.1016/j.ccr.2011.11.003.
8
Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
PLoS One. 2011;6(11):e28127. doi: 10.1371/journal.pone.0028127. Epub 2011 Nov 21.
9
Regulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligase.
PLoS One. 2011;6(11):e27464. doi: 10.1371/journal.pone.0027464. Epub 2011 Nov 8.
10
Structural linkage between ligand discrimination and receptor activation by type I interferons.
Cell. 2011 Aug 19;146(4):621-32. doi: 10.1016/j.cell.2011.06.048.
Zotero 插件